Drawing for STAR BRIGHT

USPTO serial 79153303

STAR BRIGHT

Reviewed by CopyMark Law Group

Reg. 4805985Status 404
Filing date
Status date
Registration date
Sep 8, 2015
Examiner
SOBRAL, CHRISTINA
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with STAR BRIGHT?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for the treatment and prevention of brain and central nervous system diseases and disorders; vaccines; pharmaceutical preparations and substances for the prevention and treatment of disorders and diseases in generated by or acting on the central nervous system; pharmaceutical preparations and substances acting on the central nervous system; central nervous system stimulants; pharmaceutical preparations and substances for the prevention and treatment of psychiatric and neurological disorders and diseases; pharmaceutical preparations and substances for the prevention and treatment of Alzheimer's disease and disorder, depression, psychosis, anxiety, epilepsy, multiple sclerosis, porphyria, Huntington's disease and disorder, insomnia, Parkinson's disease and disorder, schizophrenia, bipolar disorder and disease, oncology, pain, alcoholism and addiction; medical diagnostic preparations, substances, reagents and agentsSECTION 71 - CANCELLED—
042Scientific and technological services, namely, research and design in the field of medicine; industrial analysis and research services in the field of the prevention and treatment of central nervous system diseases and disorders; design and development of computer hardware and software; providing online non-downloadable software and an online searchable database in the field of research and development, science, clinical tests, diagnostic, medicine, pharmaceuticals, disorders, diseases, treatments and prevention for the purpose of scientific research; providing a secured-access website that give medical experts the ability to upload, view, download, and share documents and images for the purposes of research and development in the field of science, clinical tests, patient diagnostics, medicine, pharmaceuticals, disorders, diseases, treatments and prevention of disease; pharmaceutical research and development; scientific and technological services, namely, research in the field of medical disorders, diseases and prevention of disease; conducting clinical research and testing in the field of pharmaceuticals for others; conducting clinical research trials and testing in the field of pharmaceuticals for others; medical diagnostic research and tests, including clinical trials for others; providing medical information in the field of pharmaceutical research and development, science, clinical testsSECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 10, 2024DENANOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED—
Aug 10, 2024DETHDEATH OF INTERNATIONAL REGISTRATION—
Jan 31, 2023INNTTOTAL INVALIDATION PROCESSED BY THE IB—
Dec 19, 2022INTSTOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB—
Dec 19, 2022INPCINVALIDATION PROCESSED—
Nov 25, 2022INTRTOTAL INVALIDATION OF REG EXT PROTECTION CREATED—
Mar 25, 2022C71TCANCELLED SECTION 71—
Sep 8, 2020REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Jan 8, 2016FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Dec 18, 2015FICSFINAL DISPOSITION NOTICE SENT TO IB—
Dec 18, 2015FIMPFINAL DISPOSITION PROCESSED—
Dec 8, 2015FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Sep 8, 2015R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jun 23, 2015NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jun 23, 2015PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jun 3, 2015NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
May 15, 2015PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
May 12, 2015ALIEASSIGNED TO LIE—
Apr 21, 2015TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Apr 20, 2015CNEAEXAMINERS AMENDMENT MAILED—
Apr 20, 2015CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Apr 20, 2015XAECEXAMINER'S AMENDMENT ENTERED—
Apr 20, 2015CNEAEXAMINERS AMENDMENT -WRITTEN—
Feb 13, 2015CORRCORRECTION FROM IB ENTERED - NO REVIEW REQUIRED—
Feb 6, 2015CRCVCORRECTION TRANSACTION RECEIVED FROM IB—
Nov 8, 2014RFNTREFUSAL PROCESSED BY IB—
Oct 24, 2014MAFRAPPLICATION FILING RECEIPT MAILED—
Oct 21, 2014RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Oct 21, 2014RFRRREFUSAL PROCESSED BY MPU—
Oct 21, 2014RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Oct 20, 2014CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 20, 2014DOCKASSIGNED TO EXAMINER—
Oct 20, 2014NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Oct 17, 2014LIMILIMITATION FROM ORIGINAL APPLICATION ENTERED—
Oct 16, 2014REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance